NEW YORK--(BUSINESS WIRE)--Synchron, an implantable brain-computer interface (BCI) company, today announced the medical journal JAMA Neurology has published peer-reviewed, long-term safety results ...
The first American has been implanted with a revolutionary new brain-computer interface (BCI) at Mount Sinai Health System in New York City as part of Synchron’s COMMAND trial. This U.S. clinical ...
The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback